SCHEMBL9684147

SCHEMBL9684147

Oc1ccc(CCN(CC(O)COc2ccccc2)CC(O)COc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
BCHE P06276 2/20 0.53
ADRB3 P13945 5/20 0.50
ADRB2 P07550 4/20 0.50
ADRB1 P08588 4/20 0.50
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.49
BACE1 P56817 1/20 0.48
KCNH2 Q12809 1/20 0.46
OPRM1 P35372 1/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9684151 1.00 POLB (0.54) POLBALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL7694702 0.92 ALDH1A1 (0.64) POLBALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL7694701 0.92 ALDH1A1 (0.64) POLBALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL9685331 0.89 ALDH1A1 (0.57) POLBALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL9685334 0.89 ALDH1A1 (0.57) POLBALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL8758147 0.86 BCHE (0.71) POLBALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL27299325 0.84 ALDH1A1 (0.71) POLBALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL7689571 0.81 ALDH1A1 (0.63) POLBALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL759782 0.79 ALDH1A1 (0.67) POLBALDH1A1MAPTCYP2D6NPSR1
SCHEMBL10346703 0.79 ALDH1A1 (0.63) POLBALDH1A1MAPTCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed
EP-0140243-A2 Phenoxypropanol amines F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1985-05-08 EP disclosed